A Multi-targeted Approach to Suppress Tumor-Promoting Inflammation

Cancers harbor significant genetic heterogeneity and patterns of relapse following many therapies are due to evolved resistance to treatment. While efforts have been made to combine targeted therapies, significant levels of toxicity have stymied efforts to effectively treat cancer with multi-drug co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Semin Cancer Biol
Main Authors: Samadi, Abbas K., Georgakilas, Alexandros G., Amedei, Amedeo, Amin, Amr, Bishayee, Anupam, Lokeshwar, Bal L., Grue, Brendan, Panis, Carolina, Boosani, Chandra S., Poudyal, Deepak, Stafforini, Diana M., Bhakta, Dipita, Niccolai, Elena, Guha, Gunjan, Rupasinghe, H.P. Vasantha, Fujii, Hiromasa, Honoki, Kanya, Mehta, Kapil, Aquilano, Katia, Lowe, Leroy, Hofseth, Lorne J., Ricciardiello, Luigi, Ciriolo, Maria Rosa, Singh, Neetu, Whelan, Richard L., Chaturvedi, Rupesh, Ashraf, S. Salman, Kumara, HMC Shantha, Nowsheen, Somaira, Mohammed, Sulma I., Helferich, William G., Yang, Xujuan
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635070/
https://ncbi.nlm.nih.gov/pubmed/25951989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2015.03.006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares